Stack: Peptide & GLP-1 Tracker
Track meds, peptides & GLP-1
About
This app helps you privately track medications, peptides, and GLP-1 protocols. Log doses, calculate reconstitutions, and visualize your progress with smart schedules and reminders. Keep your routine organized without manual tracking.
What's New in Stack
1.0.6
July 12, 2026
Bug fixes
Subscription plans
1 Year subscription
1 Year subscription in Stack AI
Developer apps
FAQ
What is StackAI?
StackAI is a private tracker designed for medications, peptides, and GLP-1 protocols. It allows users to log doses, calculate reconstitutions, and review their history on a calendar.
What types of medications can I track with StackAI?
You can track GLP-1 medications like Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound), as well as a catalog of over 40 other peptides such as BPC-157, TB-500, Sermorelin, Ipamorelin, and MT-II.
Does StackAI offer reminders for doses?
Yes, StackAI allows you to create recurring schedules per medication and toggle reminders for each schedule, ensuring you receive notifications before each dose.
How does the reconstitution calculator work in StackAI?
The calculator helps you determine concentration, volume to inject, units on the syringe, syringe fill percentage, and doses per vial based on peptide amount and BAC water, built around common insulin syringe presets.
Is my data private and secure with StackAI?
StackAI is private by default, using Sign in with Apple for account creation without requiring an email or password. Your data is encrypted in transit and tied to your account for cross-device access.
What is the subscription model for StackAI?
StackAI uses an auto-renewing subscription with a free trial. Payment is charged to your Apple ID after the trial, and it renews automatically unless canceled at least 24 hours before the period ends.
What devices is StackAI available on?
Currently, StackAI is supported on iPhone devices.
How often is StackAI updated?
The latest version, 1.0.3, was released on June 24, 2026, indicating recent development activity.